Ingevity Corporation
NGVTBasic MaterialsNASDAQSpecialty Chemicals · Last scanned Sep 8, 2026
Scan Results
Daily timeframeIngevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and. At a $2.43B market cap, Ingevity Corporation ranks as a mid-cap company within basic materials. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.
Market Cap
$2.43B
Beta
1.17
P/E (TTM)
99.35
P/E (Fwd)
11.73
EPS (TTM)
$0.71
EPS (Fwd)
$6.01
ROE
30.1%
ROA
10.4%
Cash
$97.4M
Total Debt
$1.24B
Free CF
$88.9M
52W Change
20.0%
Annual Financials
Cash vs Debt
Where NGVT stands vs its 150-day and 200-day moving averages
As of the September 3, 2026 close, NGVT finished 3.75% below its 150-day moving average ($71.66) and 0.83% above its 200-day moving average ($68.40). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is NGVT overbought or oversold?
At the September 3, 2026 close, NGVT's RSI(14) was 27.2, in oversold territory (below 30). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
On the balance sheet, NGVT has $97.4M in cash with $1.24B in obligations. The ability to service this debt comfortably depends on continued operational cash generation. The company generates $88.9M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. Return on equity stands at 30.1%, which is exceptionally high for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Return on assets of 10.4% further supports the picture of efficient asset utilization. Revenue has pulled back from $1.67B (2022) to $1.17B (2025), a 30% decline worth watching.
Debt significantly exceeds cash reserves, which means the company's financial flexibility could be constrained during economic downturns. At over 50x earnings, NGVT carries valuation risk — any slowdown in growth expectations could lead to meaningful price adjustments. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Ingevity Corporation and its sector.